Viewing Study NCT00005739



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005739
Status: COMPLETED
Last Update Posted: 2015-12-23
First Post: 2000-05-25

Brief Title: Behavioral Interventions for Control of TB
Sponsor: Columbia University
Organization: Columbia University

Study Overview

Official Title: Behavioral Interventions for Control of Tuberculosis
Status: COMPLETED
Status Verified Date: 2015-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To compare alternative methods to ensure completion of treatment and preventive therapy for tuberculosis TB in inner cities and to identify the most cost-effective methods to accomplish that The basis for comparison included adherence rates and cost savings as primary outcomes and other parameters such as patient satisfaction development of social networks and participation in support programs as secondary outcomes

Two clinical trials were conducted with patients from Harlem Among those with active disease a clinic-based surrogate family model was compared to traditional community-based directly observed therapy DOT Among those eligible for preventive therapy a community-based intervention conducted by trained graduates of a TB DOT program peer workers was compared to traditional self-administered preventive treatment
Detailed Description: Tuberculosis was on the decline from the mid 1950s until the mid 1980s however the United States is now experiencing a resurgence of tuberculosis In 1992 approximately 27000 new cases were reported an increase of about 20 percent from 1985 to 1992 Not only are tuberculosis cases on the increase but a serious aspect of the problem is the recent occurence of outbreaks of multidrug resistant MDR tuberculosis which poses an urgent public health problem and requires rapid intervention

Control programs involve two major components First and of highest priority is to detect persons with active tuberculosis and treat them with effective antituberculosis drugs which prevents death from tuberculosis and stops the transmission of infection to other persons Treatment of active tuberculosis involves taking multiple antituberculosis drugs daily or several times weekly for at least six months Failure to take the medications for the full treatment period may mean that the disease is not cured and may recur If sufficient medications are not prescribed early and taken regularly the tuberculosis organism can become resistant to the drugs and the drug resistant tuberculosis then may be transmitted to other persons Drug resistant disease is difficult and expensive to treat and in some cases cannot be treated with available medications

The second major goal of control efforts is the detection and treatment of persons who do not have active tuberculosis but who have latent tuberculosis infection These people may be at high risk of developing active tuberculosis The only approved treatment modality for preventive therapy requires treatment daily or twice weekly for a minimum of six months and many patients do not complete the full course of therapy Public and patient programs are needed to increase the awareness of the problems associated with tuberculosis control

The study is part of the NHLBI initiative Behavioral Interventions for Control of Tuberculosis The concept for the initiative originated from the National Institutes of Health Working Group on Health and Behavior The Request for Applications was released in October 1994

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
R01HL055751 NIH None httpsreporternihgovquickSearchR01HL055751